Table 1 |
||||
|
Number of splenic cells/HPF that express CD4+, IL-4 and IFNγ |
||||
|
Cell numbera |
||||
|
|
||||
|
Treatment |
CD4+ |
IL-4 |
IFNγ |
IFNγ/IL-4 |
|
|
||||
|
Control |
20.67 ± 4.49 (n = 3)* |
27.00 ± 2.31 (n = 3)** |
32.23 ± 2.33 (n = 3) |
1.20 |
|
SSW |
112.00 ± 4.62 (n = 3)$, #, £ |
33.33 ± 6.69 (n = 3)§, † |
94.00 ± 7.81 (n = 3)‡ |
2.82 |
|
|
||||
|
a, Splenic lymphocyte numbers were determined by immunolabeling of spleen sections with anti-CD4. The cell numbers in the clustered staining area was estimated by the size of the cells. P > 0.05 is considered not significant change, and p < 0.001 is considered very significant change. n represents the number of different high power fields within a tissue section. *, Control/CD4+ vs. control/IL-4, and control/CD4+ vs. control/IFNγ: p > 0.05; **, control/IL-4 vs. control/IFNγ: p > 0.05, $, SSW CD4+ vs SSW IL-4: p < 0.001, and #, SSW CD4+ vs SSW/IFNγ: p > 0.05; § SSW IL-4 vs. SSW/IFNγ: p < 0.001 £, SSW CD4+ vs contol/CD4+: p < 0.001; †, SSW IL-4 vs. control/IL-4: p > 0.05; ‡, SSW/IFNγ vs control/IFNγ: p < 0.001 HPF = High Power Field |
||||
|
Yuan et al. BMC Cardiovascular Disorders 2007 7:1 doi:10.1186/1471-2261-7-1 |
||||
